Clinical Trial Update: Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bevacizumab to dex implant followed by bevacizumab in macular edema due to branch retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion with Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• DEX Implant (dexamethylprednisolone implant)

Snippet

Sponsor: Yeungnam University College of Medicine | Conditions: Branch Retinal Vein Occlusion With Macular Edema | Phase 4 | Status: UNKNOWN